TissGeneSummary for CD93 |
Gene summary |
Basic gene information | Gene symbol | CD93 |
Gene name | CD93 molecule | |
Synonyms | C1QR1|C1qR(P)|C1qRP|CDw93|ECSM3|MXRA4|dJ737E23.1 | |
Cytomap | UCSC genome browser: 20p11.21 | |
Type of gene | protein-coding | |
RefGenes | NM_012072.3, | |
Description | C1q receptor 1C1q/MBL/SPA receptorC1qRCD93 antigencomplement component 1 q subcomponent receptor 1complement component 1, q subcomponent, receptor 1complement component C1q receptormatrix-remodeling-associated protein 4matrix-remodelling associate | |
Modification date | 20141207 | |
dbXrefs | MIM : 120577 | |
HGNC : HGNC | ||
Ensembl : ENSG00000125810 | ||
HPRD : 00396 | ||
Vega : OTTHUMG00000032058 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_CD93 | |
BioGPS: 22918 | ||
Pathway | NCI Pathway Interaction Database: CD93 | |
KEGG: CD93 | ||
REACTOME: CD93 | ||
Pathway Commons: CD93 | ||
Context | iHOP: CD93 | |
ligand binding site mutation search in PubMed: CD93 | ||
UCL Cancer Institute: CD93 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | LungSoft tissue | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | LUAD,LUSCSARC | |
Reference showing the relevant tissue of CD93 | ||
Description by TissGene annotations | Cancer gene TissgsLTS |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID | GO:0016337 | single organismal cell-cell adhesion | 11994479 | GO:0016337 | single organismal cell-cell adhesion | 11994479 |
Top |
TissGeneExp for CD93 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
KIRC | 2.063460748 | 0.957219081 | 1.106241667 | 1.62E-16 | 9.17E-16 |
KIRP | -0.79877328 | 0.561173595 | -1.359946875 | 4.10E-08 | 2.74E-07 |
LUSC | -0.283527079 | 2.63339449 | -2.916921569 | 4.31E-28 | 1.43E-26 |
LUAD | 0.557826505 | 2.46034547 | -1.902518966 | 3.66E-23 | 1.17E-21 |
BLCA | -0.73245453 | 0.606824418 | -1.339278947 | 0.000264 | 0.002436249 |
Top |
TissGene-miRNA for CD93 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for CD93 |
TissGeneSNV for CD93 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.D482N | SKCM | 2 |
p.R303Q | SKCM | 2 |
p.G314E | SKCM | 2 |
p.G177D | SKCM | 1 |
p.G405D | STAD | 1 |
p.Y585H | ESCA | 1 |
p.D429H | BLCA | 1 |
p.A552T | STAD | 1 |
p.Q426K | LUAD | 1 |
p.I586T | LGG | 1 |
p.A530S | UCEC | 1 |
p.G172R | BLCA | 1 |
p.S629F | ESCA | 1 |
p.Q206X | SKCM | 1 |
p.E484Q | BLCA | 1 |
p.G363E | SKCM | 1 |
p.V428L | BRCA | 1 |
p.G491E | SKCM | 1 |
p.K324I | SKCM | 1 |
p.T528A | LUAD | 1 |
p.S629F | SKCM | 1 |
p.R607H | COAD | 1 |
p.E380D | PRAD | 1 |
p.G364D | ESCA | 1 |
p.R292W | LGG | 1 |
p.G448R | SKCM | 1 |
p.A315V | PAAD | 1 |
p.A418V | SKCM | 1 |
p.G96R | GBM | 1 |
p.V318I | COAD | 1 |
p.P375L | KIRP | 1 |
p.L532V | THCA | 1 |
p.P204L | SKCM | 1 |
p.F584L | BRCA | 1 |
p.R312S | HNSC | 1 |
p.Q356* | BRCA | 1 |
p.T647K | READ | 1 |
p.C271* | SKCM | 1 |
p.E227Q | SKCM | 1 |
p.S41L | ESCA | 1 |
p.P541S | COAD | 1 |
p.S253L | LUAD | 1 |
p.C389S | LUAD | 1 |
p.P245S | LGG | 1 |
p.D231E | LUAD | 1 |
p.T327M | LGG | 1 |
p.E618K | STAD | 1 |
p.E232K | SKCM | 1 |
p.T87M | STAD | 1 |
p.A220V | READ | 1 |
p.P510L | HNSC | 1 |
p.Q559* | SKCM | 1 |
p.S41* | LIHC | 1 |
p.G33A | LUAD | 1 |
p.A35T | ESCA | 1 |
p.R82W | ESCA | 1 |
p.F584L | LUSC | 1 |
p.T38M | STAD | 1 |
p.R496S | LUAD | 1 |
p.V568M | HNSC | 1 |
p.P378S | BLCA | 1 |
p.C396X | COAD | 1 |
p.L44M | UCEC | 1 |
p.C188* | LUAD | 1 |
p.C396W | LUAD | 1 |
p.E618K | SKCM | 1 |
p.G575A | LUAD | 1 |
p.A625T | STAD | 1 |
p.E420K | LIHC | 1 |
p.D421N | HNSC | 1 |
p.G186D | SKCM | 1 |
p.S149C | BLCA | 1 |
p.P260L | LUAD | 1 |
p.P289T | BLCA | 1 |
p.S210F | SKCM | 1 |
p.S523C | BLCA | 1 |
p.P378L | SKCM | 1 |
p.E560K | SKCM | 1 |
p.A49T | SKCM | 1 |
p.W458G | ACC | 1 |
p.V318I | STAD | 1 |
p.Q206* | SKCM | 1 |
p.E368K | SKCM | 1 |
p.G364V | BRCA | 1 |
p.G508S | SKCM | 1 |
p.P107S | SARC | 1 |
p.A88E | ESCA | 1 |
p.S170F | BLCA | 1 |
p.S41X | LIHC | 1 |
p.R607H | LUSC | 1 |
p.P632L | SKCM | 1 |
p.F182L | LIHC | 1 |
p.V318I | DLBC | 1 |
p.R609Q | LGG | 1 |
p.S210F | UCEC | 1 |
p.G113V | OV | 1 |
p.K612N | HNSC | 1 |
p.P510H | LUAD | 1 |
p.E636G | LUAD | 1 |
p.Q559K | OV | 1 |
p.G422A | HNSC | 1 |
p.F450I | LUAD | 1 |
p.N54K | LUAD | 1 |
p.P646L | UCEC | 1 |
p.G279R | SKCM | 1 |
p.L595I | LUSC | 1 |
p.A220V | LGG | 1 |
p.D337N | COAD | 1 |
p.D482N | HNSC | 1 |
p.K159* | PAAD | 1 |
p.K533R | LGG | 1 |
p.A220V | STAD | 1 |
p.E348K | SKCM | 1 |
p.D342Y | LUAD | 1 |
p.E121D | STAD | 1 |
p.E618Q | BLCA | 1 |
p.N127S | PAAD | 1 |
p.R607H | STAD | 1 |
p.S253L | STAD | 1 |
Top |
TissGeneCNV for CD93 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for CD93 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for CD93 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for CD93 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for CD93 |
TissGeneDrug for CD93 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for CD93 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0010068 | Coronary heart disease | 3 | BeFree,GAD |
umls:C0020445 | Hypercholesterolemia, Familial | 2 | GAD |
umls:C0006142 | Malignant neoplasm of breast | 1 | GAD |
umls:C0010054 | Coronary Arteriosclerosis | 1 | BeFree |
umls:C0021655 | Insulin Resistance | 1 | GAD |
umls:C0022658 | Kidney Diseases | 1 | GAD |
umls:C0024305 | Lymphoma, Non-Hodgkin | 1 | GAD |
umls:C0027051 | Myocardial Infarction | 1 | BeFree |
umls:C0030567 | Parkinson Disease | 1 | GAD |
umls:C1956346 | Coronary Artery Disease | 1 | BeFree |